Did you get your fill of pharmacy news this week? Take the Rx Roundup quiz of the week and test your knowledge about the latest stories published by the Drug Topics team from February 26 to March 1. Question 1 Abrysvo is FDA approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older. What is the durable efficacy of Abrysvo against lower respiratory tract disease with 3 or more symptoms after 2 full RSV seasons? 51.4% 77.8% 80% 98.7%Please click here after selecting answer

Source: Washington Post March 01, 2024 20:06 UTC